Tofajak-IN XR 11mg Tablet


Product Info

Prescription required Yes
Marketer Cipla Ltd
Active Ingredient Tofacitinib (11mg)
Chemical ClassPyrrolo Pyrimidine Derivative
Habit FormingNo
Therapeutic ClassPAIN ANALGESICS
Action ClassJanus kinase inhibitors
User Rating5.0
User Reviews321

FAQ

Question
Can Tofajak-IN XR 11mg cause cancer?
Tofajak-IN XR 11mg may increase the chances of developing the risk of certain cancers (lymphoma and other cancers including skin cancers) by affecting the working of the immune system. Hence, inform your doctor if you ever had or have any type of cancer.
Answer

Question
Can Tofajak-IN XR 11mg cause infections?
Tofajak-IN XR 11mg is a medicine that affects your immune system. This may reduce your ability to fight infection and may increase the risk of getting a serious infection including tuberculosis. It may also include infections caused by severe fungal, bacterial or viral infections that spread through the body. In some cases, these infections can be life-threatening and may even cause death. Hence, it is advised to treat these infections in a hospital.
Answer

Question
If I am already taking tocilizumab, can I take Tofajak-IN XR 11mg?
No, you should not take tocilizumab along with Tofajak-IN XR 11mg. Tofajak-IN XR 11mg affects the immune system, so you should avoid taking it with any other immunity-affecting medicine. Taking both medicines together can further increase the risk of infection and may lead to further complications.
Answer

Question
Can I take Tofajak-IN XR 11mg if I have liver problems?
Inform your doctor if you have liver problems, before starting Tofajak-IN XR 11mg. This is done because in some cases Tofajak-IN XR 11mg may cause an increase in liver enzymes. Therefore, your liver function needs to be investigated before starting Tofajak-IN XR 11mg. Although, Tofajak-IN XR 11mg can be given to patients with mild to moderate liver function impairment, but should not be prescribed to patients with severe liver impairment.
Answer

Question
What is Tofajak-IN XR 11mg used for?
Tofajak-IN XR 11mg is approved for use in people with moderate to severe rheumatoid arthritis. It is an inflammatory disease of the joints. It is used if previous therapy did not work well or did not suit the patient. However, it can also be used earlier in treatment if the person does not respond well to the prescribed drugs. It can be used alone or together with some other medicines, such as methotrexate.
Answer

Question
Do I need to get any investigations done before starting Tofajak-IN XR 11mg?
You may need to get your blood tests done before you start Tofajak-IN XR 11mg or while you are taking it. Blood tests are done in order to check if you have a low red blood cell count (anemia), low white blood cell count (neutropenia or lymphopenia), high blood fat (cholesterol) or high levels of liver enzymes. It also helps to ensure that treatment with Tofajak-IN XR 11mg is not causing problems. In addition to this, your doctor may advise you to get tested for tuberculosis before starting Tofajak-IN XR 11mg, as using Tofajak-IN XR 11mg may make an existing infection worse.
Answer

Question
How long does it take for Tofajak-IN XR 11mg to start working?
Tofajak-IN XR 11mg usually takes about 2 to 8 weeks before you start feeling better, and it can take 3 to 6 months to feel the maximum effect of this medication.
Answer
Question
What if you forget to take Tofajak Tablet ER?
If you miss a dose of Tofajak-IN XR 11mg, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Answer

Tofajak-IN XR 11mg Tablet Reviews

Tofajak-IN XR 11mg is used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage.

Tofajak-IN XR 11mg may be prescribed by itself or in combination with another medicine. The tablets can be taken with or without food and it is best to take them at the same time each day. Your dose will depend on your condition and what other medicines you are taking. You should use it as your doctor tells you to. Do not stop taking this medicine unless your doctor tells you to because your condition could get worse.

The most common side effects of Tofajak-IN XR 11mg include upper respiratory tract infections, headache, diarrhea, and nasopharyngitis. There are other less common side effects, some of them serious, including blood clots and tears in the stomach or intestine wall. These need urgent medical attention. If you have any worries about side effects, talk to your doctor.

You may need blood tests before you are given this medicine and you should not start taking it if you have any kind of infection. Make sure you talk to your doctor before starting treatment if you have or have ever had, tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots in your legs or lungs. Tofajak-IN XR 11mg can make you more likely to get infections or may worsen any current infections so avoid contact with people who have things you might catch (such as chickenpox, measles, flu). This medicine is not suitable for children under 18 years old and you should not use it if you are pregnant or breastfeeding, unless your doctor feels the benefit is greater than the risk. Your doctor may need to examine you regularly.

How Tofajak-IN XR 11mg Tablet Works

Tofajak-IN XR 11mg is a Janus kinase inhibitor. It works by blocking the action of the enzyme, Janus kinase. This decreases the activity of the immune system and inflammation associated with rheumatic diseases and ulcerative colitis.

How to Use Tofajak-IN XR 11mg Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tofajak-IN XR 11mg may be taken with or without food, but it is better to take it at a fixed time.

Benefits of Tofajak-IN XR 11mg Tablet

  • In Treatment of Ulcerative colitis: Ulcerative colitis is a disease of the large intestine (colon) and rectum in which the lining of the bowel becomes red and swollen. This can lead to bleeding, frequent diarrhea and abdominal pain. It relieves these symptoms and also helps you to stay well by preventing them from coming back. Drink plenty of fluids while on treatment with this medicine and stay hydrated.
  • In Treatment of Psoriatic arthritis: Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis, a condition where the skin cells in the body grow too quickly and form scales and dry patches. Psoriatic arthritis is a type of inflammatory arthritis. Symptoms include joint pain, stiffness and swelling, which may flare and subside. Tofajak-IN XR 11mg helps reduce pain, stiffness, and swelling associated with the condition. It also helps improve flexibility and prevents the disease progression. This way it helps in the management of psoriatic arthritis and enhances patients' quality of life.
  • In Treatment of Ankylosing spondylitis: Ankylosing spondylitis is a rare type of arthritis that affects the spine or larger joints. It usually starts in your lower back and can spread up to your neck or damage joints in other parts of your body. Tofajak-IN XR 11mg helps reduce pain, stiffness and swelling in your spine and joints. It helps improve flexibility and prevents disease progression. This will help you lead a better and active life.
  • In Treatment of Rheumatoid arthritis: Tofajak-IN XR 11mg works by blocking the action of some chemicals which cause inflammation. It can help reduce pain, stiffness, and swelling in your joints and slow down the progression of bone and joint damage. This will help you do normal daily activities more easily and thus improve your quality of life. This medicine should be taken at the same time each day to get maximum benefits. Keep taking the medicine even if you feel well because it is preventing future harm as well as improving your symptoms.

Uses of Tofajak-IN XR 11mg Tablet

  • Treatment of Psoriatic arthritis
  • Treatment of Rheumatoid arthritis
  • Treatment of Ankylosing spondylitis
  • Treatment of Ulcerative colitis

Tofajak-IN XR 11mg Tablet Side Effects

Item form

Safety Tips

Driving  SAFE
Tofajak-IN XR 11mg does not usually affect your ability to drive.
Breast feeding  CONSULT YOUR DOCTOR
Tofajak-IN XR 11mg is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Liver  CAUTION
Tofajak-IN XR 11mg should be used with caution in patients with severe liver disease. Dose adjustment of Tofajak-IN XR 11mg may be needed. Please consult your doctor.
Alcohol  SAFE
Consuming alcohol with Tofajak-IN XR 11mg does not cause any harmful side effects.
Kidney  CAUTION
Tofajak-IN XR 11mg should be used with caution in patients with severe kidney disease. Dose adjustment of Tofajak-IN XR 11mg may be needed. Please consult your doctor.
Pregnancy  CONSULT YOUR DOCTOR
Tofajak-IN XR 11mg may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Quick Tips

  • Inform your doctor if you are pregnant, planning to conceive, or breastfeeding.
  • Tofajak-IN XR 11mg is used alone or in combination with other medicines for the treatment of rheumatoid arthritis, that did not improve with other anti-rheumatic drugs.
  • Tofajak-IN XR 11mg can make it a bit harder for people to fight off infections. Inform your doctor if you have symptoms of an infection such as fever, chills, cough, and muscle aches.
  • It may take take 3 to 6 months to feel the maximum effect of this medication. Keep taking it as prescribed.
  • Your doctor may get TB (tuberculosis) skin test and a chest X-ray before starting treatment with this medication.
  • Your doctor may get regular blood tests done to monitor your liver function, kidney function, blood counts, or cholesterol levels.

References

  1. Central Drugs Standard Control Organisation (CDSCO). Tofacitinib.
  2. Tofacitinib. New York, New York: Pfizer Labs; 2012 [revised Nov. 2012].
  3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1373-74.
  4. Tofacitinib [Prescribing Information]. New York, NY: Pfizer labs; 2022.

Other Medical Preparations